YRF1-5 Antibody

Shipped with Ice Packs
In Stock

Description

IRF5 Antibody Overview

IRF5 (Interferon Regulatory Factor 5) is a transcription factor critical for immune regulation, cancer progression, and autoimmune diseases. Antibodies targeting IRF5 are used in research and diagnostics to study its expression, localization, and interactions.

Table 1: Validated IRF5 Antibodies and Their Applications

Antibody ID (Provider)HostClonalitySpecific ApplicationsKey Findings
10547-1-AP (Proteintech)RabbitPolyclonalWB, IHC, IF/ICC, IPDetects endogenous IRF5 in THP-1, Jurkat, and cancer tissues .
5IRF8, 5IRF10, 5IRF24 (Study )MouseMonoclonalWB, IF, IPBinds human IRF5 (not IRF-3/7); used to study nuclear import via karyopherins .
cs3257 (Cell Signaling)RabbitMonoclonalWB, Flow CytometryValidated for IRF5 knockdown studies; specific for intracellular detection .
ab124792 (Abcam)RabbitPolyclonalFlow Cytometry, IFDetects IRF5 in Ramos B cells and THP-1 monocytes with high specificity .

Table 2: IRF5 Antibody Performance in Disease Research

Disease AreaAntibody UsedFindings
Autoimmunity10547-1-AP Overexpression in lupus and rheumatoid arthritis patient tissues.
Cancer5IRF10 Detects IRF5 in breast/prostate cancer tissues; linked to tumor growth.
Viral Immunitycs3257 IRF5 knockdown reduces antiviral cytokine production in B cells.

Challenges with IRF5 Antibody Specificity

Many commercial IRF5 antibodies show cross-reactivity or fail to distinguish isoforms:

  • Non-Specific Bands: Antibodies like ab33478 (Abcam) and cs13496 (Cell Signaling) detect false-positive signals in IRF5-knockout models .

  • Species Limitations: Most antibodies target human IRF5; murine-specific variants are less common .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YRF1-5 antibody; YLR467W antibody; L9040 antibody; Y' element ATP-dependent helicase protein 1 copy 5 antibody; EC 3.6.4.12 antibody
Target Names
YRF1-5
Uniprot No.

Target Background

Function
YRF1-5 Antibody catalyzes DNA unwinding and is involved in telomerase-independent telomere maintenance.
Database Links

KEGG: sce:YDR545W

Protein Families
Helicase family, Yeast subtelomeric Y' repeat subfamily

Q&A

What are the primary applications for YRF1-5 antibodies in yeast research?

YRF1-5 antibodies can be employed across multiple experimental techniques similar to other yeast protein antibodies. Based on established immunological methods, these applications typically include:

  • Western blot analysis (WB): For detection of YRF1-5 protein expression levels

  • Immunofluorescence staining (IF): For subcellular localization studies

  • Immunoprecipitation (IP): For protein-protein interaction studies

  • Flow cytometry: For quantitative analysis of protein expression

When selecting YRF1-5 antibodies, researchers should verify each antibody has been validated for their specific application of interest, as reactivity varies considerably between techniques .

How should YRF1-5 antibody specificity be validated in yeast studies?

Proper validation of YRF1-5 antibodies requires multiple approaches:

Validation MethodProcedureControls
Western blotRun purified recombinant YRF1-5 alongside whole cell lysatesInclude YRF1-5 deletion strains as negative controls
ImmunofluorescenceCompare staining patterns in wild-type vs. mutant strainsInclude secondary-only controls
Molecular weightConfirm band appears at expected MW (~10.7 kDa)Use precise molecular weight standards

Caution is warranted as many commercial antibodies show poor specificity or cross-reactivity. In a comprehensive validation study of IRF5 antibodies (though not YRF1-5 specifically), researchers found "the majority of commercial antibodies tested were unable to specifically recognize" their target proteins .

What techniques can optimize YRF1-5 antibody development using yeast surface display?

Yeast surface display (YSD) provides a powerful platform for enhancing antibody affinity, specificity, and stability. For developing high-quality YRF1-5 antibodies, consider this methodological framework:

  • Vector construction: Insert YRF1-5-specific single-chain variable fragments (scFvs) between NheI and BamHI sites of pCTCON vector, expressed as a fusion to Aga2p yeast mating protein

  • Library generation through error-prone PCR:

    • Use nucleotide analogue mutagenesis to control mutation frequency

    • Incorporate 8-oxo-dGTP and dPTP at 200 μM and 20 μM respectively

    • Adjust PCR cycles (typically 10-25) to achieve desired mutation rate

  • Yeast transformation and selection:

    • Transform EBY100 strain using electroporation

    • Use homologous recombination for library assembly (eliminates need for ligation)

    • Achieve diversity of 10⁷-10⁸ transformants

  • Flow cytometry screening:

    • Label yeast with biotinylated YRF1-5 antigen and anti-tag antibodies

    • Use streptavidin-phycoerythrin and anti-mouse FITC secondary reagents

    • Sort cells displaying high affinity binders

The yeast display system offers advantages over other platforms, including quality control through the yeast endoplasmic reticulum, ensuring only properly folded antibodies reach the cell surface .

How can transmission electron microscopy be utilized to study YRF1-5 localization and interactions?

Immuno-electron microscopy (Immuno-EM) provides nanometer-scale resolution for studying YRF1-5 localization within cellular structures:

  • Sample preparation protocol:

    • Dispense 10 μl protein samples on carbon/Formvar-coated copper grids

    • Incubate 15-20 minutes before blotting excess

    • Wash twice with 10 μl water

  • Immunolabeling procedure:

    • Block with 2.5% bovine serum albumin/0.1% cold fish gelatin (1 hour)

    • Incubate with YRF1-5 primary antibody (1 hour)

    • Wash 5 times with blocking solution

    • Apply gold-conjugated secondary antibody (20 minutes)

    • Wash and negative-stain with 2% uranyl acetate

  • Image acquisition:

    • Collect images using transmission electron microscope (e.g., Jeol JEM-1011) operating at 80 kV

    • Focus on nuclear regions to observe telomere-associated YRF1-5

This technique has successfully visualized protein-protein interactions in yeast prion aggregates and could be adapted for YRF1-5 studies .

How can YRF1-5 antibodies be utilized to study telomerase-independent telomere maintenance?

YRF1-5's role in telomerase-independent telomere maintenance can be investigated through these methodological approaches:

  • Chromatin immunoprecipitation (ChIP):

    • Cross-link proteins to DNA with formaldehyde

    • Immunoprecipitate with YRF1-5 antibody

    • Analyze telomeric DNA enrichment by qPCR or sequencing

  • Co-immunoprecipitation for protein interaction networks:

    • Lyse cells under non-denaturing conditions

    • Immunoprecipitate with YRF1-5 antibody

    • Identify interacting partners through mass spectrometry

  • Confocal microscopy for co-localization studies:

    • Perform dual immunofluorescence with YRF1-5 and telomere markers

    • Image using laser scanning confocal microscope with Plan-Apochromat 100×/1.4 oil objective

    • Set pinhole size at 0.6 μm for optimal resolution

These approaches have successfully elucidated the roles of other telomere-associated proteins and can be adapted for YRF1-5 research.

What experimental controls are critical when investigating YRF1-5 mutant phenotypes?

When studying YRF1-5 mutant phenotypes, rigorous controls are essential:

  • Strain validation controls:

    • Confirm YRF1-5 deletion by PCR and Western blot

    • Include isogenic wild-type strains grown under identical conditions

    • Consider including strains with mutations in related YRF family members to assess functional redundancy

  • Telomere length analysis controls:

    • Compare YRF1-5 mutants to both wild-type and established telomere maintenance mutants

    • Monitor over multiple passages to observe progression of phenotypes

    • Include strains with mutations in both YRF1-5 and telomerase components

  • Antibody specificity controls:

    • Test antibody reactivity in wild-type vs. YRF1-5 deletion strains

    • Confirm the antibody does not cross-react with other YRF family proteins

    • Include epitope-tagged YRF1-5 as positive control

Research on telomere dynamics requires careful consideration of growth conditions, as expression patterns can vary significantly between logarithmic and stationary phases .

How can mass spectrometry-based proteomics enhance YRF1-5 research?

Integrating mass spectrometry with YRF1-5 immunoprecipitation provides comprehensive protein interaction networks:

  • Sample preparation workflow:

    • Immunoprecipitate YRF1-5 and associated complexes

    • Separate proteins by SDS-PAGE

    • Excise gel bands at appropriate molecular weights

    • Perform in-gel tryptic digestion

  • Mass spectrometry analysis parameters:

    • Analyze peptides using LC-MS/MS (liquid chromatography-tandem mass spectrometry)

    • Search against Saccharomyces cerevisiae protein database

    • Filter results using false discovery rate <1%

  • Data interpretation approach:

    • Classify identified proteins by cellular function

    • Use hierarchical clustering to identify functional protein groups

    • Validate key interactions through reciprocal co-immunoprecipitation

This approach has successfully identified chaperone Sis1 interactions with prion proteins and could identify novel YRF1-5 binding partners involved in telomere maintenance .

What bioinformatic approaches can predict potential cross-reactivity of YRF1-5 antibodies?

When developing or selecting YRF1-5 antibodies, bioinformatic analysis can predict potential cross-reactivity:

  • Sequence homology assessment:

    • Align epitope sequences against the full yeast proteome

    • Identify proteins with >70% sequence identity to the antibody epitope

    • Pay particular attention to other YRF family members

  • Structural epitope prediction:

    • Use tools like Epitopia or DiscoTope to identify surface-exposed epitopes

    • Select epitopes unique to YRF1-5 versus other DNA helicases

    • Avoid regions with post-translational modifications that might affect antibody binding

  • Validation planning:

    • Design experiments that test antibody against predicted cross-reactive proteins

    • Include appropriate positive and negative controls based on bioinformatic predictions

    • Consider using knockout strains of predicted cross-reactive proteins

These approaches are critical for antibody validation, as studies have shown "caution should be used in the evaluation and interpretation of protein expression analysis" due to frequent antibody cross-reactivity issues .

What strategies can address weak or inconsistent YRF1-5 signal in Western blots?

When experiencing poor signal quality with YRF1-5 antibodies in Western blots:

  • Protein extraction optimization:

    • Use specialized yeast cell lysis buffers containing protease inhibitors

    • Consider glass bead disruption for more efficient extraction

    • Test both native and denaturing extraction conditions

  • Antibody incubation parameters:

    • Optimize primary antibody concentration (typically 1:500 to 1:2000)

    • Extend incubation time (overnight at 4°C may improve signal)

    • Test different blocking agents (BSA vs. milk protein)

  • Signal enhancement approaches:

    • Use high-sensitivity chemiluminescent substrates

    • Consider biotin-streptavidin amplification systems

    • Try different membrane types (PVDF vs. nitrocellulose)

Research on IRF5 antibodies revealed that optimization of these parameters significantly improved detection specificity in challenging applications .

How can non-specific binding be reduced in YRF1-5 immunofluorescence studies?

To minimize background and improve specificity in immunofluorescence:

  • Sample preparation refinements:

    • Optimize fixation method (formaldehyde vs. methanol)

    • Test different permeabilization agents (0.1-0.5% Triton X-100)

    • Include 0.1% cold fish gelatin in blocking solution

  • Antibody incubation modifications:

    • Increase blocking time (2+ hours)

    • Pre-absorb antibodies with yeast lysates lacking YRF1-5

    • Reduce primary antibody concentration and extend incubation time

  • Imaging parameter adjustments:

    • Optimize confocal microscope settings (pinhole, gain, laser power)

    • Use spectral unmixing to separate autofluorescence from specific signal

    • Consider super-resolution techniques for detailed colocalization studies

These approaches have successfully improved signal-to-noise ratios in challenging immunofluorescence applications with other yeast proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.